Flex Pharma

About

Flex Pharma develops clinically proven products and treatments for muscle cramps and spasms.

Boston,Massachusetts,United States
1 - 10
http://www.flex-pharma.com/

Highlights

Details

Last Funding Type: Series Unknown
Last Funding Money Raised: $40M
Industries: Biotechnology,Health Care,Life Science,Medical,Medical Device,Pharmaceutical
Founded date: Jan 1, 2014
Number Of Employee: 1 - 10
Operating Status: Active
Stock Symbol: nasdaq:FLKS
Legal Name: Flex Pharma, Inc.

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps, cramps and spasms associated.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

2

$124.60M

Flex Pharma has raised a total of $124.60M in funding over 2 rounds. Their latest funding was raised on Jan 30, 2015 from a IPO round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jan 30, 2015	IPO	$84.60M	—	—	—	Detail
Sep 8, 2014	Series Unknown	$40M	14	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

—

14

Flex Pharma is funded by 14 investors. Bessemer Venture Partners and Bindley Capital Partners LLC are the most recent investors.

Investor Name	Lead Investor	Funding Round
Bessemer Venture Partners	—	Series Unknown
Bindley Capital Partners LLC	—	Series Unknown
Capital Group	—	Series Unknown
CD-Venture	—	Series Unknown
City Hill Ventures	—	Series Unknown
Correlation Ventures	—	Series Unknown
EcoR1 Capital	—	Series Unknown
Gibbs Capital Management	—	Series Unknown
Jennison Associates	—	Series Unknown
Lightstone Ventures	—	Series Unknown